Opinion: Hospital care costs are out of control. Price caps can help
Here’s just the tip of the iceberg: $722.50 for a nurse to push a drug…
Category: Medicine
Opinion: For national security, the U.S. must maintain its biotech dominance
For more than a century, the United States has been the undisputed leader in medical…
STAT+: DNA test that predicts opioid addiction should be pulled off the market, critics urge the FDA
In the next 24 hours, more than 130 people will die from opioid-related drug overdoses….
Covid cut life expectancy by 1.6 years globally, but the leading causes of death haven’t changed since 1990
The leading causes of death haven’t changed since 1990 — with one glaring, pandemic-sized exception. …
Florida accounts for 8% of U.S. abortions. Where will patients go?
Abortion access organizations say they are confronting an imminent crisis with Florida’s forthcoming six-week ban…
Parkinson’s disease may be helped by GLP-1 drug, new study finds
The booming class of GLP-1 drugs that includes Ozempic and Wegovy is not only effective…
STAT+: Mass. senators assail Steward Health Care during hearing on firm’s struggling hospitals
Senators Ed Markey and Elizabeth Warren on Wednesday slammed Steward Health Care and its embattled…
STAT+: Early data from rare-disease trial put spotlight on Moderna’s efforts to turn mRNA into medicines
LONDON — Moderna may be best known for its Covid-19 vaccine, but since its start,…
STAT+: FDA approves TriClip for tricuspid heart valve disease, pitting Abbott against Edwards
The Food and Drug Administration approved a new device from Abbott meant to treat tricuspid…
New data on liquid biopsy for colorectal cancer detection still underwhelms
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about a White House drug-shortage plan, a Genmab deal, and more
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Investors funnel $275 million into Paragon Therapeutics spinout
Investors have funneled $275 million into a revamped biotech developing new psoriasis and psoriatic arthritis…
STAT+: As AI proliferates, biopharma companies seek to harness it in clinical trials
For around 20 years, Avi Veidman spent his days in the Israeli intelligence community, analyzing…
Opinion: Medicare coverage of weight loss drugs could save the U.S. billions of dollars
The latest weight loss drugs are good. Really good. They can save lives and could…
What we know about H5N1 bird flu in cows — and the risk to humans
The discovery of H5N1 bird flu in U.S. cattle — and the news that at…
Opinion: I saw the promise of diversity efforts in health care. A moment later I saw its critical gaps
Health care was once moderately immune to the anti-diversity, anti-equity, and anti-inclusion craze. Not anymore….
STAT+: Genmab to buy ProfoundBio for $1.8 billion, the latest deal focused on targeted chemotherapies
LONDON — The Danish firm Genmab said Wednesday it would acquire ProfoundBio for $1.8 billion…
STAT+: The White House has a plan to stem drug shortages
WASHINGTON — The White House at long last published a plan to stem drug shortages,…
STAT+: Roivant CEO: New deals could ‘materialize later this year’
Can Roivant’s business model survive its success? Roivant Sciences announced two pieces of news Tuesday:…
Lawmakers want to add more Chinese biotechs to defense list
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about a European probe into vaccine talks; net drug prices falling, and more
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT+: Gritstone Bio says personalized cancer vaccine falls short in key trial
Gritstone Bio said Monday afternoon that its personalized cancer vaccine didn’t induce more responses than…
STAT+: FDA clears digital stethoscope company’s AI algorithm for heart failure
An AI algorithm to detect heart failure, embedded in a digital stethoscope, earned clearance from…
STAT+: Roivant autoimmune drug succeeds in Phase 2 study in eye condition
A drug being developed by a Roivant subsidiary for a range of autoimmune conditions succeeded…
Verve Therapeutics ‘pauses’ tests of its gene editor for heart disease and prioritizes a backup treatment
Verve Therapeutics said Tuesday that it is pausing testing of its closely watched gene-editing treatment…
STAT+: This AI company scans penis pictures for STIs. Its unproven tech is in an FDA gray zone
Artificial intelligence is already assessing decay in your teeth, abnormalities in your heart rhythm, and…
Opinion: A nation with too few pediatricians could see health care costs soar
This year’s National Residency Match, the day when medical graduates learn which health system they…
.jpg)
STAT+: Watch: Medicare billing forms are running out of space for growing health care prices
WASHINGTON — Health care costs are getting so high that prices are literally running off…
STAT+: The biotech scoreboard for the second quarter: 32 stock-moving events to watch
Here is STAT’s biotech scoreboard, our regular ledger of stock-moving biotech events, for the second…
STAT+: Biden administration sticks with slight cuts to 2025 Medicare Advantage payments
Over the past few weeks, Medicare Advantage insurers demanded that the Biden administration give them…
Florida Supreme Court upholds state’s 15-week ban on most abortions, paving way for 6-week ban
TALLAHASSEE, Fla. — The Florida Supreme Court on Monday upheld the state’s ban on most…
STAT+: Net prices for medicines fell considerably in 2023’s last quarter, mostly thanks to Humira biosimilars
The net prices that health plans paid for medicines — after subtracting rebates, discounts, and…
Why a bill meant to stop surprise medical bills hasn’t worked
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
H5N1 avian flu found in Texas man who apparently was infected by dairy cows
This is a developing story. Texas health officials reported Monday that an individual who had…
New HHS guidance requires consent for pelvic, breast, and other sensitive examinations
Hospitals performing pelvic and other sensitive exams for training purposes without patients’ explicit consent, including…
STAT+: Otsuka’s digital treatment for depression cleared by FDA, as pharma tries to crack tricky market
The Food and Drug Administration has cleared Otsuka Pharmaceutical’s digital treatment for major depressive disorder,…
Aardvark Therapeutics gearing up for $200 million IPO
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about AstraZeneca’s CEO pay, an ALS drug spat in the U.K., and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: Banning teens from social media won’t help their mental health. Here’s what might
Since the U.S. surgeon general’s 2023 advisory on social media and teen mental health, public…
STAT+: Scientists uncover potential path to treating deadly childhood tumor
Most targeted cancer drugs work like tranquilizer darts, snaring an overzealous gene that has spurred…
STAT+: Critics say U.K. decision on ALS drug could have ‘chilling effect’ on access to new genetic medicines
LONDON — Neurologists and patient advocates are up in arms over a policy decision by…
STAT+: UnitedHealth’s surprising new target: Struggling Steward’s physician group
UnitedHealth Group has gobbled up physician practices at an astounding rate — roughly 20,000 last…
GLP-1 generics would be dramatically cheaper than U.S. price of Ozempic, study shows, but still profitable
Diabetes drugs are too expensive in the U.S., and insulin is infamously six to 13…
People in Republican-voting states more likely to report Covid-19 vaccine side effects, study says
People in Republican-voting states were more likely to report adverse events after receiving a Covid-19…
STAT+: Pharmalittle: We’re reading about Wegovy insurance coverage, Zepbound shortages, and more
And so, another working week will soon draw to a close. Not a moment too…
What’s Congress going to do with WuXi?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Why researchers think human milk could repair the gut microbiome and reduce infections
For babies who are breastfed, their first source of sustenance is filled with proteins, sugars,…
STAT+: Washington wants to avert another Change Healthcare-like fiasco. Here’s what could be coming
Washington is cracking down on the technology running behind the scenes in health care following…
Opinion: The U.S. needs a bipartisan industrial policy for the life sciences
President Biden’s efforts to revitalize the nation’s technology-based industries, which began with semiconductors and electric…
Listen: What the mifepristone case means, GLP-1 skepticism, & Chinese biotech
Who gets to sue the FDA? Is pharma caught in a trade war? And what…